EstroGene database reveals diverse temporal, context-dependent and directional estrogen receptor regulomes in breast cancer
Li, Z.; Li, T.; Yates, M. E.; Wu, Y.; Ferber, A.; Chen, L.; Brown, D. D.; Carroll, J.; Sikora, M. J.; Tseng, G.; Oesterreich, S.; LEE, A. V.
Show abstract
As one of the most successful cancer therapeutic targets, estrogen receptor- (ER/ESR1) has been extensively studied in decade-long. Sequencing technological advances have enabled genome-wide analysis of ER action. However, reproducibility is limited by different experimental design. Here, we established the EstroGene database through centralizing 246 experiments from 136 transcriptomic, cistromic and epigenetic datasets focusing on estradiol-treated ER activation across 19 breast cancer cell lines. We generated a user-friendly browser (https://estrogene.org/) for data visualization and gene inquiry under user-defined experimental conditions and statistical thresholds. Notably, documentation-based meta-analysis revealed a considerable lack of experimental details. Comparison of independent RNA-seq or ER ChIP-seq data with the same design showed large variability and only strong effects could be consistently detected. We defined temporal estrogen response metasignatures and showed the association with specific transcriptional factors, chromatin accessibility and ER heterogeneity. Unexpectedly, harmonizing 146 transcriptomic analyses uncovered a subset of E2-bidirectionally regulated genes, which linked to immune surveillance in the clinical setting. Furthermore, we defined context dependent E2 response programs in MCF7 and T47D cell lines, the two most frequently used models in the field. Collectively, the EstroGene database provides an informative resource to the cancer research community and reveals a diverse mode of ER signaling.
Matching journals
The top 7 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- Chromatin accessibility landscape and active transcription factors in primary human invasive lobular and ductal breast carcinomas 96%
- Towards resolution of the intron retention paradox in breast cancer 94%
- Loss of chromosome cytoband 13q14.2 orchestrates breast cancer pathogenesis and drug response 94%
Similar papers in this journal
- Estrogen receptor alpha mutations in breast cancer cells cause gene expression changes through constant activity and through secondary effects 95%
- Pan-cancer Drivers are Recurrent Transcriptional Regulatory Heterogeneities in Early-stage Luminal Breast Cancer 94%
- Single cell transcriptomic heterogeneity in invasive ductal and lobular breast cancer cells 94%
Similar papers in this journal
- CRISPR/Cas9 screen reveals a role of purine synthesis for estrogen receptor α activity and tamoxifen resistance of breast cancer cells 95%
- The gene regulatory landscape driving mouse gonadal supporting cell differentiation 94%
- Aneuploidy and deregulated DNA damage response define haploinsufficiency in breast tissues of BRCA2 mutation carriers 94%
Similar papers in this journal
- Breast cancer risk SNPs converge on estrogen receptor binding sites commonly shared between breast tumors to locally alter estrogen signalling output 97%
- Estrogen-induced chromatin looping changes identify a subset of functional regulatory elements 96%
- Estrogen-independent molecular actions of mutant estrogen receptor alpha in endometrial cancer 95%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.